780 per cent returns in this multibagger penny stock below Rs 60; Company receives an order worth Rs 28,02,800 from Attar!
780 per cent returns in this multibagger penny stock below Rs 60; Company receives an order worth Rs 28,02,800 from Attar!

780 per cent returns in this multibagger penny stock below Rs 60; Company receives an order worth Rs 28,02,800 from Attar!

The shares of the company have a ROE of 31.80 per cent and a ROCE of 39 per cent.

Kiran Shroff Article rating: 4.3

According to the quarterly results, the net sales increased by 185 per cent to Rs 43.1 crore and net profit increased by 137 per cent to Rs 1.68 crore in Q1FY24 over Q1FY23. According to the annual results, the net sales increased by 93 per cent to Rs 114 crore and net profit increased by 350 per cent to Rs 5 crore in FY23 over FY22.

600 per cent returns: Heavy buying witnessed in this multibagger micro-cap stock as company receives multiple orders!
600 per cent returns: Heavy buying witnessed in this multibagger micro-cap stock as company receives multiple orders!

600 per cent returns: Heavy buying witnessed in this multibagger micro-cap stock as company receives multiple orders!

The shares of the company have a ROE of 31.80 per cent and a ROCE of 39 per cent.

Kiran Shroff Article rating: 3.8

The company has a market cap of Rs 132 crore and is almost debt-free, with only Rs 1.61 crore in debt. This represents just 1.22 per cent of its current market cap. The stock gave multibagger returns of 300 per cent in 2 years and over 600 per cent in 3 years.

Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?
Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?

Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?

After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario.

Mandar Wagh Article rating: 5.0

After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario. 

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR